Raposas, Jerald L.
HRN: 22-45-32 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/16/2023
01/18/2023
IV
600mg
Q6hrs
Fracture Open III B, M/3rd, Femur, Left
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes